On June 18, 2020, RSMC American Reproductive Science Medical Center and Noah Fortune, a well-known financial platform in China, launched a special lecture during the epidemic in Noah’s First Time.
Guest RSMC reproductive science medical center “American virus academic circles one of the three carriages” Kathryn V, Dr Holmes and drugs biological spanish-american director Dr Xue defensibly Dijon, Inovionovel coronavirus vaccine development director Dr Trevor Smith and RSMC reproductive science medical center scientists Dr Grace Jin, virologists gathered in China and the United States to discuss the world for both human and virus.
In this lecture, guests made a detailed interpretation of the origin of the virus, whether to enter the phase of viral herd immunity in the future, the development stage of coVID-19 vaccine, and when to put it into clinical trials.
Before the lecture began, Dr. Grace Jin, a scientist from RSMC American Fertility Medical Center, who initiated the forum, gave a brief introduction to the distinguished guests. Each of them is a leading figure in the Medical field in the United States.
The first speaker is Dr. Kathryn V Holmes, who is honored as “The American Academician Li Lanjuan”. Dr. Kathryn V Holmes is a recognized expert on Mars and SARS virus in the world. Dr. Kathryn V Holmes first Shared with you the development history of coronavirus, and then made an analysis of the differences of Mars, SARS and coronavirus.
Kathryn V Holmes, Ph.D., graduated from Rockefeller University in 1968 and devoted her life to the study of the structure and function of virus receptors. She was President of the American Viral Society from 1993 to 1994.
She is recognized worldwide as an expert on SARS and Middle East Respiratory syndrome (MERS).
Invited by the American Society of Virology to give a keynote speech on the development of coronavirus at the 2020 Conference.
“The three viruses are very different from each other in terms of the epidemic,” said Kathryn V Holmes. “They are very different in terms of the route of transmission, the virulence of the virus itself and the duration of the epidemic. Each virus is unique.”
As for how long the novel Coronavirus will last, Dr. Kathryn V Holmes said that the scientific community cannot predict with certainty, “Coronavirus will undergo genetic recombination in the process of replication, and the virus variation is endless, which will hinder the development of vaccines against viruses for human beings”.
For will guard against coronavirus, Dr Holmes also puts forward many ideas, Kathryn V “quarantine can slow down the speed, and we don’t know what survivors who carry the virus or is immune and which survivors have no immunity, so you need to track contact with infected people, quarantine and track contact with infected people is very important!”
Dr. Kathryn V Holmes reiterated that “avoiding parties and social gatherings is also a way to respect life,” Dr. Grace Jin added.
Dr. Grace Jin graduated from Fudan University majoring in genetics.
After receiving his doctorate in molecular biology and biochemistry in the United States, he has been engaged in medical teaching and pharmacological research in American universities.
Joined RSMC in 2018.)
Novel Coronavirus may coexist with humans in the future?
“I believe it will be coronavirus spread to every corner of the world, we have already seen will be coronavirus infection so sharply their ears, the future is likely to be one of the world in the world every year local outbreak will be coronavirus, but want to outbreak can become softer, because a lot of people may have infected will be coronavirus, people may also form a herd immunity effect.”
Kathryn V Holmes answers accordingly.
Finally, Dr Holmes Kathryn V on effective drugs of most concern of make a very positive answer: “I think that before the invention of the vaccine is effective drugs is meeting some, I predicted at the end of this year or next year there will be a effective drugs, and now in used for various diseases such as cancer treatment, the immune system of drugs are also used for will be coronavirus drugs in the development of the”.
Then, Dr. Trevor Smith Shared information on the current phase of vaccine development.
(Dr. Trevor Smith is a molecular and cellular immunologist.
He has a PhD from Imperial University in London and is a postdoctoral fellow at Scripps Research Centre, where he has worked on vaccines for respiratory viruses, influenza viruses and tumours.
More recently, Inovio Pharmaceuticals has led the development of a DNA vaccine from novel Coronavirus.)
“The novel coronavirusRNA sequence is the novel technique we are using to design a new vaccine that demonstrates a very good immune response but requires further experimentation to prove it.
We must have a better and faster response to the outbreak in the future!”
“Says Trevor Smith.
The outbreak of the “new crown for our scientific community, is a bad thing is good, is a loud warning to all mankind, is the humanity awakening, tells us to respect for life, respect for each species, the fight will be coronavirus is the mission of all mankind, every countries should work together to fight the virus” Dr Grace Jin at the end of the lecture pleaded.
May the novel Coronavirus end soon and the life of the world soon be back on track!
Headquartered in the beautiful coastal southern California city of San Diego, RSMC is the nation’s first comprehensive reproductive health care group that provides end-to-end “closed loop health care system” for healthy birth and child care.
RSMC American Reproductive Science Medical Center provides U.S. third generation IVF, frozen eggs, frozen embryos, legal love for pregnancy, stem cell regeneration therapy and other services to customers from around the world.
In its 21 years since its founding in 1995, RSMC has recorded more than 10,000 cases of IVF and 5,000 cases of love-assisted pregnancy.
RSMC offers more than 40 personalized treatments using third-generation test-tube technology — the most advanced PGS/PGD pre-implantation genetic screening for diagnosis — and third-party assisted reproductive services to achieve a high test-tube success rate, ensuring that all patients receive tailored treatment